Cargando…

Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies

BACKGROUND: UK local authorities that experienced sustained high levels of COVID-19 between 1st March 2020 and 28th February 2021 were described by the UK Scientific Advisory Group for Emergencies as areas of enduring prevalence. This research was carried out in order to examine the views of local a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Catherine, Johnson, Sheena, Hartwig, Angelique, Ubido, Janet, Coleman, Anna, Gartland, Nicola, Kamal, Atiya, Gaokar, Amit, Armitage, Christopher J., Fishwick, David, van Tongeren, Martie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286421/
https://www.ncbi.nlm.nih.gov/pubmed/37344781
http://dx.doi.org/10.1186/s12889-023-15723-7
_version_ 1785061744881696768
author Lewis, Catherine
Johnson, Sheena
Hartwig, Angelique
Ubido, Janet
Coleman, Anna
Gartland, Nicola
Kamal, Atiya
Gaokar, Amit
Armitage, Christopher J.
Fishwick, David
van Tongeren, Martie
author_facet Lewis, Catherine
Johnson, Sheena
Hartwig, Angelique
Ubido, Janet
Coleman, Anna
Gartland, Nicola
Kamal, Atiya
Gaokar, Amit
Armitage, Christopher J.
Fishwick, David
van Tongeren, Martie
author_sort Lewis, Catherine
collection PubMed
description BACKGROUND: UK local authorities that experienced sustained high levels of COVID-19 between 1st March 2020 and 28th February 2021 were described by the UK Scientific Advisory Group for Emergencies as areas of enduring prevalence. This research was carried out in order to examine the views of local authority Directors of Public Health, who played a crucial role in the local response to COVID-19, on reasons for sustained high levels of prevalence in some areas, alongside an investigation of the mitigation strategies that they implemented during the course of the pandemic. METHODS: Interviews were conducted with Directors of Public Health in 19 local authority areas across England, between July and November 2021. This included nine areas identified as areas of enduring prevalence and ten ‘comparison’ areas. RESULTS: The outcomes of this study suggests that the geographical differences in prevalence rates are strongly influenced by health inequalities. Structural factors including deprivation, employment, and housing, due to their disproportionate impact on specific groups, converged with demographic factors, including ethnicity and age, and vaccination rates, and were identified as the main drivers of enduring prevalence. There are key differences in these drivers both within and, to a lesser extent, between local authorities. Other than these structural barriers, no major differences in facilitators or barriers to COVID-19 mitigation were identified between areas of varying prevalence. The main features of successful mitigation strategies were a locally tailored approach and partnership working involving local authority departments working with local health, community, voluntary and business organisations. CONCLUSIONS: This study is the first to add the voices of Directors of Public Health, who played a crucial role in the local COVID-19 response. Areas of enduring prevalence existed during the pandemic which were caused by a complex mix of structural factors related to inequalities. Participants advised that more research is needed on the effectiveness of mitigation strategies and other measures to reduce the impact of structural inequalities, to better understand the factors that drive prevalence. This would include an assessment of how these factors combine to predict transmission and how this varies between different areas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15723-7.
format Online
Article
Text
id pubmed-10286421
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102864212023-06-23 Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies Lewis, Catherine Johnson, Sheena Hartwig, Angelique Ubido, Janet Coleman, Anna Gartland, Nicola Kamal, Atiya Gaokar, Amit Armitage, Christopher J. Fishwick, David van Tongeren, Martie BMC Public Health Research BACKGROUND: UK local authorities that experienced sustained high levels of COVID-19 between 1st March 2020 and 28th February 2021 were described by the UK Scientific Advisory Group for Emergencies as areas of enduring prevalence. This research was carried out in order to examine the views of local authority Directors of Public Health, who played a crucial role in the local response to COVID-19, on reasons for sustained high levels of prevalence in some areas, alongside an investigation of the mitigation strategies that they implemented during the course of the pandemic. METHODS: Interviews were conducted with Directors of Public Health in 19 local authority areas across England, between July and November 2021. This included nine areas identified as areas of enduring prevalence and ten ‘comparison’ areas. RESULTS: The outcomes of this study suggests that the geographical differences in prevalence rates are strongly influenced by health inequalities. Structural factors including deprivation, employment, and housing, due to their disproportionate impact on specific groups, converged with demographic factors, including ethnicity and age, and vaccination rates, and were identified as the main drivers of enduring prevalence. There are key differences in these drivers both within and, to a lesser extent, between local authorities. Other than these structural barriers, no major differences in facilitators or barriers to COVID-19 mitigation were identified between areas of varying prevalence. The main features of successful mitigation strategies were a locally tailored approach and partnership working involving local authority departments working with local health, community, voluntary and business organisations. CONCLUSIONS: This study is the first to add the voices of Directors of Public Health, who played a crucial role in the local COVID-19 response. Areas of enduring prevalence existed during the pandemic which were caused by a complex mix of structural factors related to inequalities. Participants advised that more research is needed on the effectiveness of mitigation strategies and other measures to reduce the impact of structural inequalities, to better understand the factors that drive prevalence. This would include an assessment of how these factors combine to predict transmission and how this varies between different areas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15723-7. BioMed Central 2023-06-21 /pmc/articles/PMC10286421/ /pubmed/37344781 http://dx.doi.org/10.1186/s12889-023-15723-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lewis, Catherine
Johnson, Sheena
Hartwig, Angelique
Ubido, Janet
Coleman, Anna
Gartland, Nicola
Kamal, Atiya
Gaokar, Amit
Armitage, Christopher J.
Fishwick, David
van Tongeren, Martie
Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title_full Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title_fullStr Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title_full_unstemmed Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title_short Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies
title_sort areas of enduring covid-19 prevalence: drivers of prevalence and mitigating strategies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286421/
https://www.ncbi.nlm.nih.gov/pubmed/37344781
http://dx.doi.org/10.1186/s12889-023-15723-7
work_keys_str_mv AT lewiscatherine areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT johnsonsheena areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT hartwigangelique areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT ubidojanet areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT colemananna areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT gartlandnicola areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT kamalatiya areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT gaokaramit areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT armitagechristopherj areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT fishwickdavid areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies
AT vantongerenmartie areasofenduringcovid19prevalencedriversofprevalenceandmitigatingstrategies